| Tipifarnib |
ENSG00000104691.10 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Tipifarnib |
ENSG00000126005.11 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000132832.5 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tipifarnib |
ENSG00000146666.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000146666.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000160336.10 |
Predicted lncRNA |
Sarcoma |
|
| Tipifarnib |
ENSG00000171671.6 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000174365.15 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Tipifarnib |
ENSG00000175061.13 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Tipifarnib |
ENSG00000177640.11 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tipifarnib |
ENSG00000178412.4 |
Predicted lncRNA |
Esophageal cancer |
|
| Tipifarnib |
ENSG00000179219.5 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Tipifarnib |
ENSG00000180279.5 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tipifarnib |
ENSG00000180422.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tipifarnib |
ENSG00000180846.4 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tipifarnib |
ENSG00000181798.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Tipifarnib |
ENSG00000182057.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000182310.8 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Tipifarnib |
ENSG00000182648.7 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Tipifarnib |
ENSG00000182648.7 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000183535.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000184274.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000185203.7 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000186019.10 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000186056.5 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tipifarnib |
ENSG00000189223.9 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tipifarnib |
ENSG00000189229.10 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000196559.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tipifarnib |
ENSG00000196951.6 |
Predicted lncRNA |
Esophageal cancer |
|
| Tipifarnib |
ENSG00000197291.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000197813.4 |
Predicted lncRNA |
Esophageal cancer |
|
| Tipifarnib |
ENSG00000198221.7 |
Predicted lncRNA |
Sarcoma |
|
| Tipifarnib |
ENSG00000203258.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tipifarnib |
ENSG00000203258.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000203499.6 |
Predicted lncRNA |
Esophageal cancer |
|
| Tipifarnib |
ENSG00000203801.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000204272.6 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tipifarnib |
ENSG00000204380.2 |
Predicted lncRNA |
Sarcoma |
|
| Tipifarnib |
ENSG00000204934.6 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tipifarnib |
ENSG00000205054.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Tipifarnib |
ENSG00000205663.5 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Tipifarnib |
ENSG00000205885.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Tipifarnib |
ENSG00000205959.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tipifarnib |
ENSG00000206129.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Tipifarnib |
ENSG00000206567.5 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tipifarnib |
ENSG00000212163.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tipifarnib |
ENSG00000212163.2 |
Predicted lncRNA |
Sarcoma |
|
| Tipifarnib |
ENSG00000213742.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Tipifarnib |
ENSG00000213863.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000213994.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000214401.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000214559.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Tipifarnib |
ENSG00000214772.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Tipifarnib |
ENSG00000214922.5 |
Predicted lncRNA |
Esophageal cancer |
|
| Tipifarnib |
ENSG00000215039.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000215417.6 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tipifarnib |
ENSG00000215692.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Tipifarnib |
ENSG00000215869.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tipifarnib |
ENSG00000217258.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tipifarnib |
ENSG00000218839.3 |
Predicted lncRNA |
Sarcoma |
|
| Tipifarnib |
ENSG00000219665.4 |
Predicted lncRNA |
Sarcoma |
|
| Tipifarnib |
ENSG00000220161.4 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Tipifarnib |
ENSG00000220161.4 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Tipifarnib |
ENSG00000222041.6 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Tipifarnib |
ENSG00000222043.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tipifarnib |
ENSG00000222043.2 |
Predicted lncRNA |
Sarcoma |
|
| Tipifarnib |
ENSG00000223356.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000223390.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Tipifarnib |
ENSG00000223393.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Tipifarnib |
ENSG00000223477.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000223477.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Tipifarnib |
ENSG00000223528.3 |
Predicted lncRNA |
Sarcoma |
|
| Tipifarnib |
ENSG00000223576.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tipifarnib |
ENSG00000223692.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tipifarnib |
ENSG00000223704.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tipifarnib |
ENSG00000223711.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tipifarnib |
ENSG00000223725.2 |
Predicted lncRNA |
Sarcoma |
|
| Tipifarnib |
ENSG00000223759.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000223779.4 |
Predicted lncRNA |
Sarcoma |
|
| Tipifarnib |
ENSG00000223804.1 |
Predicted lncRNA |
Sarcoma |
|
| Tipifarnib |
ENSG00000223834.2 |
Predicted lncRNA |
Sarcoma |
|
| Tipifarnib |
ENSG00000223839.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tipifarnib |
ENSG00000223884.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000223935.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Tipifarnib |
ENSG00000224046.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Tipifarnib |
ENSG00000224049.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000224057.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Tipifarnib |
ENSG00000224074.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000224079.1 |
Predicted lncRNA |
Sarcoma |
|
| Tipifarnib |
ENSG00000224093.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Tipifarnib |
ENSG00000224189.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tipifarnib |
ENSG00000224269.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Tipifarnib |
ENSG00000224441.1 |
Predicted lncRNA |
Sarcoma |
|
| Tipifarnib |
ENSG00000224535.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000224559.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tipifarnib |
ENSG00000224574.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000224687.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Tipifarnib |
ENSG00000224698.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tipifarnib |
ENSG00000224733.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000224789.1 |
Predicted lncRNA |
Sarcoma |
|
| Tipifarnib |
ENSG00000224805.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tipifarnib |
ENSG00000224819.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000224844.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tipifarnib |
ENSG00000224848.1 |
Predicted lncRNA |
Sarcoma |
|
| Tipifarnib |
ENSG00000224855.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tipifarnib |
ENSG00000224875.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000224899.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Tipifarnib |
ENSG00000224950.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tipifarnib |
ENSG00000224959.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Tipifarnib |
ENSG00000224969.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000224973.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000224992.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tipifarnib |
ENSG00000225037.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000225037.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tipifarnib |
ENSG00000225087.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000225092.2 |
Predicted lncRNA |
Sarcoma |
|
| Tipifarnib |
ENSG00000225111.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Tipifarnib |
ENSG00000225113.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000225113.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tipifarnib |
ENSG00000225177.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000225234.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000225265.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tipifarnib |
ENSG00000225302.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000225376.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000225518.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tipifarnib |
ENSG00000225527.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000225619.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000225643.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tipifarnib |
ENSG00000225676.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000225684.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000225745.4 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Tipifarnib |
ENSG00000225745.4 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tipifarnib |
ENSG00000225764.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tipifarnib |
ENSG00000225778.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tipifarnib |
ENSG00000225798.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tipifarnib |
ENSG00000225836.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000225850.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000225937.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000225937.1 |
Predicted lncRNA |
Sarcoma |
|
| Tipifarnib |
ENSG00000225953.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000225956.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tipifarnib |
ENSG00000226009.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Tipifarnib |
ENSG00000226009.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tipifarnib |
ENSG00000226067.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000226091.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000226194.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tipifarnib |
ENSG00000226381.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Tipifarnib |
ENSG00000226508.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tipifarnib |
ENSG00000226526.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000226533.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000226574.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000226609.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tipifarnib |
ENSG00000226609.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Tipifarnib |
ENSG00000226637.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Tipifarnib |
ENSG00000226637.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000226637.1 |
Predicted lncRNA |
Sarcoma |
|
| Tipifarnib |
ENSG00000226812.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tipifarnib |
ENSG00000226816.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tipifarnib |
ENSG00000226824.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tipifarnib |
ENSG00000226842.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000226853.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Tipifarnib |
ENSG00000226853.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tipifarnib |
ENSG00000226889.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tipifarnib |
ENSG00000226913.1 |
Predicted lncRNA |
Sarcoma |
|
| Tipifarnib |
ENSG00000226921.2 |
Predicted lncRNA |
Sarcoma |
|
| Tipifarnib |
ENSG00000226950.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tipifarnib |
ENSG00000226957.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000227016.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000227036.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000227050.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000227060.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000227071.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tipifarnib |
ENSG00000227128.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000227136.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000227218.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tipifarnib |
ENSG00000227248.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000227285.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000227372.6 |
Predicted lncRNA |
Sarcoma |
|
| Tipifarnib |
ENSG00000227375.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000227484.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tipifarnib |
ENSG00000227484.1 |
Predicted lncRNA |
Sarcoma |
|
| Tipifarnib |
ENSG00000227486.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tipifarnib |
ENSG00000227487.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000227495.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tipifarnib |
ENSG00000227502.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tipifarnib |
ENSG00000227502.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000227542.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000227589.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Tipifarnib |
ENSG00000227678.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000227811.2 |
Predicted lncRNA |
Sarcoma |
|
| Tipifarnib |
ENSG00000227959.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000228065.6 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tipifarnib |
ENSG00000228079.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000228113.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tipifarnib |
ENSG00000228139.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000228172.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tipifarnib |
ENSG00000228192.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Tipifarnib |
ENSG00000228237.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tipifarnib |
ENSG00000228242.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tipifarnib |
ENSG00000228323.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tipifarnib |
ENSG00000228340.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Tipifarnib |
ENSG00000228481.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000228509.1 |
Predicted lncRNA |
Sarcoma |
|
| Tipifarnib |
ENSG00000228554.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tipifarnib |
ENSG00000228629.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tipifarnib |
ENSG00000228630.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000228705.1 |
Predicted lncRNA |
Sarcoma |
|
| Tipifarnib |
ENSG00000228741.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tipifarnib |
ENSG00000228742.5 |
Predicted lncRNA |
Sarcoma |
|
| Tipifarnib |
ENSG00000228748.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tipifarnib |
ENSG00000228824.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Tipifarnib |
ENSG00000228826.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000228839.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000228939.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000229017.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tipifarnib |
ENSG00000229043.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000229044.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000229056.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000229122.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000229137.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tipifarnib |
ENSG00000229153.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Tipifarnib |
ENSG00000229154.1 |
Predicted lncRNA |
Sarcoma |
|
| Tipifarnib |
ENSG00000229162.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tipifarnib |
ENSG00000229178.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tipifarnib |
ENSG00000229263.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tipifarnib |
ENSG00000229311.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Tipifarnib |
ENSG00000229331.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000229379.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000229404.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000229521.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tipifarnib |
ENSG00000229647.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Tipifarnib |
ENSG00000229647.1 |
Predicted lncRNA |
Sarcoma |
|
| Tipifarnib |
ENSG00000229660.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tipifarnib |
ENSG00000229697.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Tipifarnib |
ENSG00000229697.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tipifarnib |
ENSG00000229739.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tipifarnib |
ENSG00000229780.1 |
Predicted lncRNA |
Sarcoma |
|
| Tipifarnib |
ENSG00000229801.1 |
Predicted lncRNA |
Sarcoma |
|
| Tipifarnib |
ENSG00000229841.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Tipifarnib |
ENSG00000229841.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tipifarnib |
ENSG00000229848.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tipifarnib |
ENSG00000229852.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tipifarnib |
ENSG00000229950.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Tipifarnib |
ENSG00000229952.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000229983.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tipifarnib |
ENSG00000230013.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000230091.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tipifarnib |
ENSG00000230212.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000230262.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tipifarnib |
ENSG00000230310.1 |
Predicted lncRNA |
Sarcoma |
|
| Tipifarnib |
ENSG00000230310.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tipifarnib |
ENSG00000230333.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000230337.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Tipifarnib |
ENSG00000230394.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000230424.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Tipifarnib |
ENSG00000230439.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Tipifarnib |
ENSG00000230470.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tipifarnib |
ENSG00000230479.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000230534.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tipifarnib |
ENSG00000230537.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000230550.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000230563.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000230613.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Tipifarnib |
ENSG00000230648.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tipifarnib |
ENSG00000230698.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Tipifarnib |
ENSG00000230736.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000230747.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tipifarnib |
ENSG00000230753.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tipifarnib |
ENSG00000230825.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Tipifarnib |
ENSG00000230836.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Tipifarnib |
ENSG00000230940.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000231050.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000231050.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Tipifarnib |
ENSG00000231125.2 |
Predicted lncRNA |
Sarcoma |
|
| Tipifarnib |
ENSG00000231131.2 |
Predicted lncRNA |
Sarcoma |
|
| Tipifarnib |
ENSG00000231154.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Tipifarnib |
ENSG00000231187.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000231187.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Tipifarnib |
ENSG00000231210.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000231210.2 |
Predicted lncRNA |
Sarcoma |
|
| Tipifarnib |
ENSG00000231291.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000231393.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000231437.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000231507.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tipifarnib |
ENSG00000231512.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tipifarnib |
ENSG00000231528.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000231646.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000231663.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Tipifarnib |
ENSG00000231709.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tipifarnib |
ENSG00000231709.1 |
Predicted lncRNA |
Sarcoma |
|
| Tipifarnib |
ENSG00000231711.2 |
Predicted lncRNA |
Sarcoma |
|
| Tipifarnib |
ENSG00000231734.4 |
Predicted lncRNA |
Sarcoma |
|
| Tipifarnib |
ENSG00000231742.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000231770.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000231806.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000231842.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000231918.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tipifarnib |
ENSG00000231943.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Tipifarnib |
ENSG00000231948.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000231964.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000231992.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tipifarnib |
ENSG00000232104.2 |
Predicted lncRNA |
Sarcoma |
|
| Tipifarnib |
ENSG00000232233.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Tipifarnib |
ENSG00000232300.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000232325.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000232386.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000232453.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tipifarnib |
ENSG00000232455.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000232504.4 |
Predicted lncRNA |
Esophageal cancer |
|
| Tipifarnib |
ENSG00000232504.4 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tipifarnib |
ENSG00000232519.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tipifarnib |
ENSG00000232527.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tipifarnib |
ENSG00000232555.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000232640.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tipifarnib |
ENSG00000232712.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000232754.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000232884.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000232900.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tipifarnib |
ENSG00000232909.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000232936.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tipifarnib |
ENSG00000232949.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000233016.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tipifarnib |
ENSG00000233038.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000233058.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tipifarnib |
ENSG00000233101.6 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000233203.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tipifarnib |
ENSG00000233223.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Tipifarnib |
ENSG00000233223.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Tipifarnib |
ENSG00000233244.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tipifarnib |
ENSG00000233246.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Tipifarnib |
ENSG00000233250.1 |
Predicted lncRNA |
Sarcoma |
|
| Tipifarnib |
ENSG00000233332.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000233368.2 |
Predicted lncRNA |
Sarcoma |
|
| Tipifarnib |
ENSG00000233411.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tipifarnib |
ENSG00000233427.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tipifarnib |
ENSG00000233461.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tipifarnib |
ENSG00000233593.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000233672.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tipifarnib |
ENSG00000233694.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tipifarnib |
ENSG00000233766.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000233797.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000233799.1 |
Predicted lncRNA |
Sarcoma |
|
| Tipifarnib |
ENSG00000233818.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Tipifarnib |
ENSG00000233818.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000233893.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tipifarnib |
ENSG00000233893.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tipifarnib |
ENSG00000233895.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tipifarnib |
ENSG00000233903.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000233903.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tipifarnib |
ENSG00000233912.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000234050.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000234076.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Tipifarnib |
ENSG00000234076.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tipifarnib |
ENSG00000234149.1 |
Predicted lncRNA |
Sarcoma |
|
| Tipifarnib |
ENSG00000234156.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000234160.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tipifarnib |
ENSG00000234245.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000234449.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Tipifarnib |
ENSG00000234456.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000234492.4 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tipifarnib |
ENSG00000234509.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Tipifarnib |
ENSG00000234698.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Tipifarnib |
ENSG00000234699.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000234707.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tipifarnib |
ENSG00000234779.1 |
Predicted lncRNA |
Sarcoma |
|
| Tipifarnib |
ENSG00000234818.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tipifarnib |
ENSG00000234869.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000234913.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tipifarnib |
ENSG00000234942.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000235007.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000235016.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Tipifarnib |
ENSG00000235077.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tipifarnib |
ENSG00000235119.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tipifarnib |
ENSG00000235152.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tipifarnib |
ENSG00000235192.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tipifarnib |
ENSG00000235209.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tipifarnib |
ENSG00000235326.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tipifarnib |
ENSG00000235337.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000235358.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Tipifarnib |
ENSG00000235381.1 |
Predicted lncRNA |
Sarcoma |
|
| Tipifarnib |
ENSG00000235387.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000235398.4 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Tipifarnib |
ENSG00000235398.4 |
Predicted lncRNA |
Sarcoma |
|
| Tipifarnib |
ENSG00000235407.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Tipifarnib |
ENSG00000235445.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000235470.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000235475.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000235493.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000235526.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000235545.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tipifarnib |
ENSG00000235586.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tipifarnib |
ENSG00000235593.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000235609.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000235643.1 |
Predicted lncRNA |
Sarcoma |
|
| Tipifarnib |
ENSG00000235702.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Tipifarnib |
ENSG00000235779.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tipifarnib |
ENSG00000235781.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000235802.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tipifarnib |
ENSG00000235806.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tipifarnib |
ENSG00000235831.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Tipifarnib |
ENSG00000235837.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tipifarnib |
ENSG00000235872.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000235927.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tipifarnib |
ENSG00000235999.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000236017.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tipifarnib |
ENSG00000236091.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000236095.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tipifarnib |
ENSG00000236115.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tipifarnib |
ENSG00000236153.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Tipifarnib |
ENSG00000236199.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000236199.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tipifarnib |
ENSG00000236256.5 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Tipifarnib |
ENSG00000236266.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tipifarnib |
ENSG00000236266.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000236337.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Tipifarnib |
ENSG00000236434.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Tipifarnib |
ENSG00000236451.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000236472.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000236514.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000236519.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tipifarnib |
ENSG00000236520.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000236545.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tipifarnib |
ENSG00000236618.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Tipifarnib |
ENSG00000236651.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000236830.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tipifarnib |
ENSG00000236850.4 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tipifarnib |
ENSG00000236869.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000236871.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tipifarnib |
ENSG00000236943.2 |
Predicted lncRNA |
Sarcoma |
|
| Tipifarnib |
ENSG00000237015.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tipifarnib |
ENSG00000237073.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tipifarnib |
ENSG00000237076.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000237126.4 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tipifarnib |
ENSG00000237133.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Tipifarnib |
ENSG00000237159.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000237166.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tipifarnib |
ENSG00000237187.4 |
Predicted lncRNA |
Sarcoma |
|
| Tipifarnib |
ENSG00000237248.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tipifarnib |
ENSG00000237338.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000237373.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tipifarnib |
ENSG00000237410.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000237424.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000237436.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tipifarnib |
ENSG00000237438.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Tipifarnib |
ENSG00000237438.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tipifarnib |
ENSG00000237476.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000237485.1 |
Predicted lncRNA |
Sarcoma |
|
| Tipifarnib |
ENSG00000237505.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000237520.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tipifarnib |
ENSG00000237523.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tipifarnib |
ENSG00000237525.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tipifarnib |
ENSG00000237595.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000237685.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000237689.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000237807.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000237857.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000237886.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000237892.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000237899.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tipifarnib |
ENSG00000237928.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000237934.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tipifarnib |
ENSG00000237940.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000237943.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Tipifarnib |
ENSG00000237945.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tipifarnib |
ENSG00000237978.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000237980.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tipifarnib |
ENSG00000238005.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tipifarnib |
ENSG00000238018.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000238039.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Tipifarnib |
ENSG00000238057.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000238062.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tipifarnib |
ENSG00000238113.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Tipifarnib |
ENSG00000238123.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tipifarnib |
ENSG00000238123.1 |
Predicted lncRNA |
Sarcoma |
|
| Tipifarnib |
ENSG00000238133.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tipifarnib |
ENSG00000238141.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tipifarnib |
ENSG00000238160.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Tipifarnib |
ENSG00000238164.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000238197.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Tipifarnib |
ENSG00000238279.1 |
Predicted lncRNA |
Sarcoma |
|
| Tipifarnib |
ENSG00000238280.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tipifarnib |
ENSG00000238290.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Tipifarnib |
ENSG00000239213.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Tipifarnib |
ENSG00000239498.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000240211.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Tipifarnib |
ENSG00000240219.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tipifarnib |
ENSG00000240254.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000240291.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Tipifarnib |
ENSG00000240350.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Tipifarnib |
ENSG00000240401.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000240549.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000240859.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Tipifarnib |
ENSG00000240907.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000240922.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000241163.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tipifarnib |
ENSG00000241219.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000241479.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Tipifarnib |
ENSG00000241570.4 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Tipifarnib |
ENSG00000241570.4 |
Predicted lncRNA |
Sarcoma |
|
| Tipifarnib |
ENSG00000241684.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000241770.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tipifarnib |
ENSG00000241886.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Tipifarnib |
ENSG00000241933.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000241954.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000242207.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000242396.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tipifarnib |
ENSG00000242474.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Tipifarnib |
ENSG00000242516.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Tipifarnib |
ENSG00000242759.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Tipifarnib |
ENSG00000242795.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000242797.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000242808.3 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Tipifarnib |
ENSG00000243193.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000243389.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000243433.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tipifarnib |
ENSG00000243533.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tipifarnib |
ENSG00000243701.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tipifarnib |
ENSG00000243795.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tipifarnib |
ENSG00000243902.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Tipifarnib |
ENSG00000243960.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tipifarnib |
ENSG00000243967.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tipifarnib |
ENSG00000244203.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000244260.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000244286.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000244327.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000244332.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Tipifarnib |
ENSG00000244380.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tipifarnib |
ENSG00000244558.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Tipifarnib |
ENSG00000244675.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tipifarnib |
ENSG00000244733.4 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tipifarnib |
ENSG00000245060.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tipifarnib |
ENSG00000245080.4 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tipifarnib |
ENSG00000245112.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000245148.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tipifarnib |
ENSG00000245293.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tipifarnib |
ENSG00000245729.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Tipifarnib |
ENSG00000245928.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tipifarnib |
ENSG00000245928.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tipifarnib |
ENSG00000246174.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tipifarnib |
ENSG00000246323.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tipifarnib |
ENSG00000246394.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000246422.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tipifarnib |
ENSG00000246523.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000246582.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tipifarnib |
ENSG00000246763.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Tipifarnib |
ENSG00000246763.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tipifarnib |
ENSG00000246792.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tipifarnib |
ENSG00000246792.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tipifarnib |
ENSG00000246859.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tipifarnib |
ENSG00000247363.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Tipifarnib |
ENSG00000247498.5 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tipifarnib |
ENSG00000247624.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000247624.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tipifarnib |
ENSG00000247675.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Tipifarnib |
ENSG00000247774.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tipifarnib |
ENSG00000247925.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tipifarnib |
ENSG00000247970.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Tipifarnib |
ENSG00000248079.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Tipifarnib |
ENSG00000248079.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Tipifarnib |
ENSG00000248125.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000248152.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000248161.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tipifarnib |
ENSG00000248161.1 |
Predicted lncRNA |
Sarcoma |
|
| Tipifarnib |
ENSG00000248206.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Tipifarnib |
ENSG00000248221.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000248245.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000248309.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Tipifarnib |
ENSG00000248323.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Tipifarnib |
ENSG00000248323.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Tipifarnib |
ENSG00000248356.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tipifarnib |
ENSG00000248445.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tipifarnib |
ENSG00000248479.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000248599.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tipifarnib |
ENSG00000248690.2 |
Predicted lncRNA |
Sarcoma |
|
| Tipifarnib |
ENSG00000248719.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Tipifarnib |
ENSG00000248925.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tipifarnib |
ENSG00000248936.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000248973.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Tipifarnib |
ENSG00000248973.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000248980.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tipifarnib |
ENSG00000248996.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000249028.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000249084.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Tipifarnib |
ENSG00000249159.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Tipifarnib |
ENSG00000249207.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000249252.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tipifarnib |
ENSG00000249375.3 |
Predicted lncRNA |
Sarcoma |
|
| Tipifarnib |
ENSG00000249381.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tipifarnib |
ENSG00000249430.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Tipifarnib |
ENSG00000249478.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000249487.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tipifarnib |
ENSG00000249621.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000249641.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tipifarnib |
ENSG00000249684.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tipifarnib |
ENSG00000249740.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000249740.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Tipifarnib |
ENSG00000249859.3 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Tipifarnib |
ENSG00000249868.4 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tipifarnib |
ENSG00000249894.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000249916.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Tipifarnib |
ENSG00000250027.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tipifarnib |
ENSG00000250056.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000250057.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000250061.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000250131.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Tipifarnib |
ENSG00000250131.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tipifarnib |
ENSG00000250132.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tipifarnib |
ENSG00000250159.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000250230.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000250240.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Tipifarnib |
ENSG00000250260.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tipifarnib |
ENSG00000250303.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Tipifarnib |
ENSG00000250366.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000250409.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000250421.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000250582.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000250692.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000250714.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tipifarnib |
ENSG00000250742.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000250786.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tipifarnib |
ENSG00000250820.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tipifarnib |
ENSG00000250846.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000250999.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Tipifarnib |
ENSG00000251003.3 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Tipifarnib |
ENSG00000251022.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000251136.4 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Tipifarnib |
ENSG00000251136.4 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tipifarnib |
ENSG00000251136.4 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Tipifarnib |
ENSG00000251148.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tipifarnib |
ENSG00000251161.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tipifarnib |
ENSG00000251168.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000251175.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000251292.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000251320.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000251323.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tipifarnib |
ENSG00000251330.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Tipifarnib |
ENSG00000251330.3 |
Predicted lncRNA |
Sarcoma |
|
| Tipifarnib |
ENSG00000251350.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000251523.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000251603.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Tipifarnib |
ENSG00000251675.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Tipifarnib |
ENSG00000253112.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tipifarnib |
ENSG00000253116.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000253210.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tipifarnib |
ENSG00000253256.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000253298.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000253315.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tipifarnib |
ENSG00000253317.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tipifarnib |
ENSG00000253327.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Tipifarnib |
ENSG00000253404.1 |
Predicted lncRNA |
Sarcoma |
|
| Tipifarnib |
ENSG00000253438.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000253515.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000253526.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000253552.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000253563.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000253632.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tipifarnib |
ENSG00000253669.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tipifarnib |
ENSG00000253737.1 |
Predicted lncRNA |
Sarcoma |
|
| Tipifarnib |
ENSG00000253744.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000253744.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tipifarnib |
ENSG00000253754.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tipifarnib |
ENSG00000253829.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Tipifarnib |
ENSG00000253854.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Tipifarnib |
ENSG00000253911.1 |
Predicted lncRNA |
Sarcoma |
|
| Tipifarnib |
ENSG00000254057.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Tipifarnib |
ENSG00000254057.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000254081.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Tipifarnib |
ENSG00000254109.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tipifarnib |
ENSG00000254109.1 |
Predicted lncRNA |
Sarcoma |
|
| Tipifarnib |
ENSG00000254154.4 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tipifarnib |
ENSG00000254222.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000254315.1 |
Predicted lncRNA |
Sarcoma |
|
| Tipifarnib |
ENSG00000254317.1 |
Predicted lncRNA |
Sarcoma |
|
| Tipifarnib |
ENSG00000254409.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000254427.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000254432.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tipifarnib |
ENSG00000254459.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Tipifarnib |
ENSG00000254480.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000254526.1 |
Predicted lncRNA |
Sarcoma |
|
| Tipifarnib |
ENSG00000254554.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Tipifarnib |
ENSG00000254556.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000254556.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000254610.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Tipifarnib |
ENSG00000254615.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000254648.1 |
Predicted lncRNA |
Sarcoma |
|
| Tipifarnib |
ENSG00000254686.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000254687.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tipifarnib |
ENSG00000254694.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tipifarnib |
ENSG00000254812.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tipifarnib |
ENSG00000254826.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tipifarnib |
ENSG00000254826.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000254839.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000254855.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tipifarnib |
ENSG00000254869.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tipifarnib |
ENSG00000254910.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tipifarnib |
ENSG00000254936.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000254936.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000254966.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000254991.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tipifarnib |
ENSG00000255027.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000255089.1 |
Predicted lncRNA |
Sarcoma |
|
| Tipifarnib |
ENSG00000255089.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tipifarnib |
ENSG00000255121.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tipifarnib |
ENSG00000255143.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Tipifarnib |
ENSG00000255153.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tipifarnib |
ENSG00000255165.1 |
Predicted lncRNA |
Sarcoma |
|
| Tipifarnib |
ENSG00000255320.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tipifarnib |
ENSG00000255326.1 |
Predicted lncRNA |
Sarcoma |
|
| Tipifarnib |
ENSG00000255343.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000255348.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000255400.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Tipifarnib |
ENSG00000255478.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000255509.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000255557.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Tipifarnib |
ENSG00000255651.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tipifarnib |
ENSG00000255693.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000255723.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000255808.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000255916.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000255968.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Tipifarnib |
ENSG00000255989.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Tipifarnib |
ENSG00000256006.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Tipifarnib |
ENSG00000256008.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tipifarnib |
ENSG00000256050.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tipifarnib |
ENSG00000256092.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Tipifarnib |
ENSG00000256092.2 |
Predicted lncRNA |
Sarcoma |
|
| Tipifarnib |
ENSG00000256128.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tipifarnib |
ENSG00000256195.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000256250.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000256250.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000256250.1 |
Predicted lncRNA |
Sarcoma |
|
| Tipifarnib |
ENSG00000256299.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000256325.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000256458.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tipifarnib |
ENSG00000256588.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000256588.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tipifarnib |
ENSG00000256705.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000256746.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000256967.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000257027.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Tipifarnib |
ENSG00000257058.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000257086.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tipifarnib |
ENSG00000257114.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tipifarnib |
ENSG00000257114.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Tipifarnib |
ENSG00000257135.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tipifarnib |
ENSG00000257222.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Tipifarnib |
ENSG00000257272.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000257285.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000257391.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tipifarnib |
ENSG00000257429.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000257507.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tipifarnib |
ENSG00000257557.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000257557.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tipifarnib |
ENSG00000257636.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000257660.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Tipifarnib |
ENSG00000257702.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tipifarnib |
ENSG00000257808.1 |
Predicted lncRNA |
Sarcoma |
|
| Tipifarnib |
ENSG00000257815.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Tipifarnib |
ENSG00000257880.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000257886.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Tipifarnib |
ENSG00000257947.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tipifarnib |
ENSG00000257953.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tipifarnib |
ENSG00000258171.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tipifarnib |
ENSG00000258240.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Tipifarnib |
ENSG00000258303.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tipifarnib |
ENSG00000258323.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tipifarnib |
ENSG00000258344.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tipifarnib |
ENSG00000258345.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000258345.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tipifarnib |
ENSG00000258410.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tipifarnib |
ENSG00000258413.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Tipifarnib |
ENSG00000258422.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000258457.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000258458.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tipifarnib |
ENSG00000258520.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000258521.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000258535.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000258553.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000258561.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Tipifarnib |
ENSG00000258602.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000258658.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tipifarnib |
ENSG00000258730.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tipifarnib |
ENSG00000258760.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000258821.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tipifarnib |
ENSG00000258821.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tipifarnib |
ENSG00000258871.1 |
Predicted lncRNA |
Sarcoma |
|
| Tipifarnib |
ENSG00000258914.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000258929.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000258952.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000258959.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000259031.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tipifarnib |
ENSG00000259058.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000259070.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000259158.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000259158.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tipifarnib |
ENSG00000259206.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tipifarnib |
ENSG00000259230.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000259238.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Tipifarnib |
ENSG00000259245.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000259274.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Tipifarnib |
ENSG00000259274.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000259287.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tipifarnib |
ENSG00000259327.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000259345.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000259364.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000259376.1 |
Predicted lncRNA |
Sarcoma |
|
| Tipifarnib |
ENSG00000259377.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000259410.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tipifarnib |
ENSG00000259436.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tipifarnib |
ENSG00000259437.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000259444.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000259453.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000259473.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000259475.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tipifarnib |
ENSG00000259523.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tipifarnib |
ENSG00000259523.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000259583.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000259589.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000259606.2 |
Predicted lncRNA |
Sarcoma |
|
| Tipifarnib |
ENSG00000259635.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tipifarnib |
ENSG00000259694.1 |
Predicted lncRNA |
Sarcoma |
|
| Tipifarnib |
ENSG00000259704.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000259709.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000259709.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000259711.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Tipifarnib |
ENSG00000259714.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000259717.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000259760.1 |
Predicted lncRNA |
Sarcoma |
|
| Tipifarnib |
ENSG00000259774.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000259774.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tipifarnib |
ENSG00000259797.1 |
Predicted lncRNA |
Sarcoma |
|
| Tipifarnib |
ENSG00000259805.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tipifarnib |
ENSG00000259818.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000259831.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000259834.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000259884.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tipifarnib |
ENSG00000259886.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000259886.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tipifarnib |
ENSG00000259899.1 |
Predicted lncRNA |
Sarcoma |
|
| Tipifarnib |
ENSG00000259935.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000259953.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000259959.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000259964.2 |
Predicted lncRNA |
Sarcoma |
|
| Tipifarnib |
ENSG00000260000.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tipifarnib |
ENSG00000260017.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tipifarnib |
ENSG00000260037.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000260063.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Tipifarnib |
ENSG00000260065.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tipifarnib |
ENSG00000260088.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Tipifarnib |
ENSG00000260118.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tipifarnib |
ENSG00000260132.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tipifarnib |
ENSG00000260156.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tipifarnib |
ENSG00000260167.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tipifarnib |
ENSG00000260196.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000260206.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tipifarnib |
ENSG00000260206.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000260213.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Tipifarnib |
ENSG00000260233.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tipifarnib |
ENSG00000260233.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Tipifarnib |
ENSG00000260236.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Tipifarnib |
ENSG00000260260.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tipifarnib |
ENSG00000260260.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tipifarnib |
ENSG00000260261.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Tipifarnib |
ENSG00000260269.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000260285.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Tipifarnib |
ENSG00000260296.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000260302.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000260316.1 |
Predicted lncRNA |
Sarcoma |
|
| Tipifarnib |
ENSG00000260336.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Tipifarnib |
ENSG00000260366.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Tipifarnib |
ENSG00000260368.1 |
Predicted lncRNA |
Sarcoma |
|
| Tipifarnib |
ENSG00000260396.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000260398.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000260409.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Tipifarnib |
ENSG00000260436.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tipifarnib |
ENSG00000260448.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tipifarnib |
ENSG00000260473.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000260526.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Tipifarnib |
ENSG00000260526.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Tipifarnib |
ENSG00000260534.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000260583.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000260583.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000260588.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Tipifarnib |
ENSG00000260600.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000260608.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tipifarnib |
ENSG00000260613.1 |
Predicted lncRNA |
Sarcoma |
|
| Tipifarnib |
ENSG00000260616.2 |
Predicted lncRNA |
Sarcoma |
|
| Tipifarnib |
ENSG00000260618.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000260641.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Tipifarnib |
ENSG00000260643.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tipifarnib |
ENSG00000260647.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Tipifarnib |
ENSG00000260796.1 |
Predicted lncRNA |
Sarcoma |
|
| Tipifarnib |
ENSG00000260805.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tipifarnib |
ENSG00000260871.1 |
Predicted lncRNA |
Sarcoma |
|
| Tipifarnib |
ENSG00000260905.1 |
Predicted lncRNA |
Sarcoma |
|
| Tipifarnib |
ENSG00000260911.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Tipifarnib |
ENSG00000260911.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tipifarnib |
ENSG00000260924.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Tipifarnib |
ENSG00000260924.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tipifarnib |
ENSG00000260938.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tipifarnib |
ENSG00000260942.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Tipifarnib |
ENSG00000260948.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000260973.1 |
Predicted lncRNA |
Sarcoma |
|
| Tipifarnib |
ENSG00000260978.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Tipifarnib |
ENSG00000260988.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tipifarnib |
ENSG00000260989.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000261068.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tipifarnib |
ENSG00000261068.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Tipifarnib |
ENSG00000261092.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Tipifarnib |
ENSG00000261123.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tipifarnib |
ENSG00000261187.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000261195.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000261211.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Tipifarnib |
ENSG00000261253.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000261273.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000261326.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tipifarnib |
ENSG00000261334.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000261353.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tipifarnib |
ENSG00000261355.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000261373.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tipifarnib |
ENSG00000261374.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000261384.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000261390.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tipifarnib |
ENSG00000261392.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000261420.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tipifarnib |
ENSG00000261428.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tipifarnib |
ENSG00000261428.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Tipifarnib |
ENSG00000261431.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tipifarnib |
ENSG00000261434.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tipifarnib |
ENSG00000261451.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000261455.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Tipifarnib |
ENSG00000261455.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tipifarnib |
ENSG00000261512.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tipifarnib |
ENSG00000261533.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tipifarnib |
ENSG00000261534.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Tipifarnib |
ENSG00000261534.1 |
Predicted lncRNA |
Sarcoma |
|
| Tipifarnib |
ENSG00000261550.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Tipifarnib |
ENSG00000261574.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tipifarnib |
ENSG00000261584.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tipifarnib |
ENSG00000261600.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tipifarnib |
ENSG00000261634.2 |
Predicted lncRNA |
Sarcoma |
|
| Tipifarnib |
ENSG00000261670.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000261693.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Tipifarnib |
ENSG00000261697.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tipifarnib |
ENSG00000261716.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tipifarnib |
ENSG00000261728.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000261780.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tipifarnib |
ENSG00000261798.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tipifarnib |
ENSG00000261801.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000261823.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Tipifarnib |
ENSG00000261827.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tipifarnib |
ENSG00000261971.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000261996.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000262006.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tipifarnib |
ENSG00000262089.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Tipifarnib |
ENSG00000262094.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000262094.1 |
Predicted lncRNA |
Sarcoma |
|
| Tipifarnib |
ENSG00000262136.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000262136.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Tipifarnib |
ENSG00000262136.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000262147.1 |
Predicted lncRNA |
Sarcoma |
|
| Tipifarnib |
ENSG00000262152.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tipifarnib |
ENSG00000262179.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000262202.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Tipifarnib |
ENSG00000262298.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tipifarnib |
ENSG00000262410.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000262412.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tipifarnib |
ENSG00000262454.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tipifarnib |
ENSG00000262529.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000262652.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000262745.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000262766.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Tipifarnib |
ENSG00000262833.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tipifarnib |
ENSG00000262879.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Tipifarnib |
ENSG00000262881.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000262888.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Tipifarnib |
ENSG00000262952.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tipifarnib |
ENSG00000262952.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000262973.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tipifarnib |
ENSG00000263004.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tipifarnib |
ENSG00000263080.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tipifarnib |
ENSG00000263098.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000263105.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000263321.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000263338.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tipifarnib |
ENSG00000263345.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tipifarnib |
ENSG00000263388.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tipifarnib |
ENSG00000263499.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000263551.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Tipifarnib |
ENSG00000263603.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tipifarnib |
ENSG00000263680.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000263745.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000263753.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Tipifarnib |
ENSG00000263765.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000263847.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000263862.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000263874.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000263884.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tipifarnib |
ENSG00000263895.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tipifarnib |
ENSG00000263924.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000264023.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000264222.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Tipifarnib |
ENSG00000264456.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000264647.1 |
Predicted lncRNA |
Sarcoma |
|
| Tipifarnib |
ENSG00000264672.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tipifarnib |
ENSG00000264672.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Tipifarnib |
ENSG00000264673.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000264812.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tipifarnib |
ENSG00000264812.1 |
Predicted lncRNA |
Sarcoma |
|
| Tipifarnib |
ENSG00000264860.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tipifarnib |
ENSG00000265043.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000265128.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000265130.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000265185.2 |
Predicted lncRNA |
Sarcoma |
|
| Tipifarnib |
ENSG00000265204.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000265349.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000265496.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tipifarnib |
ENSG00000265496.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000265542.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000265656.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tipifarnib |
ENSG00000265666.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tipifarnib |
ENSG00000265688.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tipifarnib |
ENSG00000265728.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000265908.1 |
Predicted lncRNA |
Sarcoma |
|
| Tipifarnib |
ENSG00000266149.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000266290.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000266290.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tipifarnib |
ENSG00000266401.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000266469.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tipifarnib |
ENSG00000266521.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000266554.1 |
Predicted lncRNA |
Sarcoma |
|
| Tipifarnib |
ENSG00000266654.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tipifarnib |
ENSG00000266718.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000266783.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Tipifarnib |
ENSG00000266900.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Tipifarnib |
ENSG00000266926.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tipifarnib |
ENSG00000266927.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Tipifarnib |
ENSG00000266930.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Tipifarnib |
ENSG00000266947.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000266947.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000266957.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000266957.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tipifarnib |
ENSG00000266965.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000266993.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000267006.1 |
Predicted lncRNA |
Sarcoma |
|
| Tipifarnib |
ENSG00000267044.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tipifarnib |
ENSG00000267063.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tipifarnib |
ENSG00000267141.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tipifarnib |
ENSG00000267152.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tipifarnib |
ENSG00000267159.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tipifarnib |
ENSG00000267167.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000267174.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tipifarnib |
ENSG00000267211.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tipifarnib |
ENSG00000267219.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tipifarnib |
ENSG00000267263.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tipifarnib |
ENSG00000267280.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000267280.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000267280.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tipifarnib |
ENSG00000267282.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tipifarnib |
ENSG00000267308.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tipifarnib |
ENSG00000267316.1 |
Predicted lncRNA |
Sarcoma |
|
| Tipifarnib |
ENSG00000267317.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000267321.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tipifarnib |
ENSG00000267338.1 |
Predicted lncRNA |
Sarcoma |
|
| Tipifarnib |
ENSG00000267372.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Tipifarnib |
ENSG00000267373.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000267375.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000267474.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Tipifarnib |
ENSG00000267474.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tipifarnib |
ENSG00000267475.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Tipifarnib |
ENSG00000267475.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tipifarnib |
ENSG00000267530.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Tipifarnib |
ENSG00000267547.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000267547.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tipifarnib |
ENSG00000267565.1 |
Predicted lncRNA |
Sarcoma |
|
| Tipifarnib |
ENSG00000267567.1 |
Predicted lncRNA |
Sarcoma |
|
| Tipifarnib |
ENSG00000267568.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Tipifarnib |
ENSG00000267586.2 |
Predicted lncRNA |
Sarcoma |
|
| Tipifarnib |
ENSG00000267638.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tipifarnib |
ENSG00000267667.1 |
Predicted lncRNA |
Sarcoma |
|
| Tipifarnib |
ENSG00000267672.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000267672.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000267711.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000267737.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000267745.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000267745.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tipifarnib |
ENSG00000267759.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000267764.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Tipifarnib |
ENSG00000267858.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Tipifarnib |
ENSG00000267858.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tipifarnib |
ENSG00000267874.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000267927.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000268015.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tipifarnib |
ENSG00000268027.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000268189.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Tipifarnib |
ENSG00000268257.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tipifarnib |
ENSG00000268307.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000268499.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000268568.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tipifarnib |
ENSG00000268573.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000268670.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000268707.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tipifarnib |
ENSG00000268743.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Tipifarnib |
ENSG00000268751.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Tipifarnib |
ENSG00000268912.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000268945.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tipifarnib |
ENSG00000269054.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tipifarnib |
ENSG00000269066.1 |
Predicted lncRNA |
Sarcoma |
|
| Tipifarnib |
ENSG00000269091.1 |
Predicted lncRNA |
Sarcoma |
|
| Tipifarnib |
ENSG00000269102.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tipifarnib |
ENSG00000269194.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tipifarnib |
ENSG00000269194.1 |
Predicted lncRNA |
Sarcoma |
|
| Tipifarnib |
ENSG00000269246.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Tipifarnib |
ENSG00000269365.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000269365.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000269400.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000269473.1 |
Predicted lncRNA |
Sarcoma |
|
| Tipifarnib |
ENSG00000269574.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tipifarnib |
ENSG00000269653.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000269694.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tipifarnib |
ENSG00000269895.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000269906.1 |
Predicted lncRNA |
Sarcoma |
|
| Tipifarnib |
ENSG00000269910.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Tipifarnib |
ENSG00000269923.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000269929.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tipifarnib |
ENSG00000269940.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Tipifarnib |
ENSG00000269951.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tipifarnib |
ENSG00000269956.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tipifarnib |
ENSG00000269956.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Tipifarnib |
ENSG00000269976.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000269983.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Tipifarnib |
ENSG00000269990.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tipifarnib |
ENSG00000270012.1 |
Predicted lncRNA |
Sarcoma |
|
| Tipifarnib |
ENSG00000270015.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tipifarnib |
ENSG00000270028.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000270040.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tipifarnib |
ENSG00000270041.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tipifarnib |
ENSG00000270052.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000270066.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tipifarnib |
ENSG00000270100.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000270109.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tipifarnib |
ENSG00000270109.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Tipifarnib |
ENSG00000270130.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000270137.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000270140.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000270154.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000270157.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Tipifarnib |
ENSG00000270178.1 |
Predicted lncRNA |
Sarcoma |
|
| Tipifarnib |
ENSG00000270184.1 |
Predicted lncRNA |
Sarcoma |
|
| Tipifarnib |
ENSG00000270419.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tipifarnib |
ENSG00000270426.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000270426.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Tipifarnib |
ENSG00000270522.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tipifarnib |
ENSG00000270557.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000270641.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Tipifarnib |
ENSG00000270673.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Tipifarnib |
ENSG00000270681.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tipifarnib |
ENSG00000270720.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000270761.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tipifarnib |
ENSG00000270828.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tipifarnib |
ENSG00000270866.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Tipifarnib |
ENSG00000270876.1 |
Predicted lncRNA |
Sarcoma |
|
| Tipifarnib |
ENSG00000270933.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tipifarnib |
ENSG00000270949.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tipifarnib |
ENSG00000270951.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tipifarnib |
ENSG00000271086.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000271119.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000271199.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tipifarnib |
ENSG00000271228.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tipifarnib |
ENSG00000271259.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000271265.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tipifarnib |
ENSG00000271335.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tipifarnib |
ENSG00000271420.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tipifarnib |
ENSG00000271646.1 |
Predicted lncRNA |
Sarcoma |
|
| Tipifarnib |
ENSG00000271715.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000271752.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tipifarnib |
ENSG00000271757.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000271782.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000271789.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Tipifarnib |
ENSG00000271835.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tipifarnib |
ENSG00000271857.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000271857.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tipifarnib |
ENSG00000271869.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tipifarnib |
ENSG00000271916.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000271921.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tipifarnib |
ENSG00000271948.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000271964.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000271975.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Tipifarnib |
ENSG00000271992.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tipifarnib |
ENSG00000271996.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tipifarnib |
ENSG00000271997.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Tipifarnib |
ENSG00000272010.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tipifarnib |
ENSG00000272024.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tipifarnib |
ENSG00000272029.1 |
Predicted lncRNA |
Sarcoma |
|
| Tipifarnib |
ENSG00000272070.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000272070.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tipifarnib |
ENSG00000272076.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000272088.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Tipifarnib |
ENSG00000272091.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000272102.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tipifarnib |
ENSG00000272128.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Tipifarnib |
ENSG00000272130.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000272130.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tipifarnib |
ENSG00000272138.1 |
Predicted lncRNA |
Sarcoma |
|
| Tipifarnib |
ENSG00000272142.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000272142.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tipifarnib |
ENSG00000272143.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000272143.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tipifarnib |
ENSG00000272144.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tipifarnib |
ENSG00000272146.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tipifarnib |
ENSG00000272148.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000272181.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000272183.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tipifarnib |
ENSG00000272198.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tipifarnib |
ENSG00000272205.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tipifarnib |
ENSG00000272221.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000272225.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000272226.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000272254.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Tipifarnib |
ENSG00000272263.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000272301.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tipifarnib |
ENSG00000272301.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000272320.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000272334.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tipifarnib |
ENSG00000272341.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tipifarnib |
ENSG00000272366.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000272369.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000272386.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Tipifarnib |
ENSG00000272389.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tipifarnib |
ENSG00000272416.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tipifarnib |
ENSG00000272426.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tipifarnib |
ENSG00000272432.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tipifarnib |
ENSG00000272449.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tipifarnib |
ENSG00000272455.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tipifarnib |
ENSG00000272462.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tipifarnib |
ENSG00000272473.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000272508.1 |
Predicted lncRNA |
Sarcoma |
|
| Tipifarnib |
ENSG00000272516.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000272525.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Tipifarnib |
ENSG00000272529.1 |
Predicted lncRNA |
Sarcoma |
|
| Tipifarnib |
ENSG00000272562.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tipifarnib |
ENSG00000272562.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Tipifarnib |
ENSG00000272567.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Tipifarnib |
ENSG00000272576.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000272597.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000272622.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Tipifarnib |
ENSG00000272660.1 |
Predicted lncRNA |
Sarcoma |
|
| Tipifarnib |
ENSG00000272699.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000272699.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tipifarnib |
ENSG00000272699.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000272699.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tipifarnib |
ENSG00000272709.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Tipifarnib |
ENSG00000272716.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tipifarnib |
ENSG00000272716.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tipifarnib |
ENSG00000272717.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Tipifarnib |
ENSG00000272719.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Tipifarnib |
ENSG00000272744.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000272746.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000272760.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Tipifarnib |
ENSG00000272763.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000272769.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Tipifarnib |
ENSG00000272777.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000272789.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tipifarnib |
ENSG00000272792.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tipifarnib |
ENSG00000272798.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tipifarnib |
ENSG00000272799.1 |
Predicted lncRNA |
Sarcoma |
|
| Tipifarnib |
ENSG00000272823.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tipifarnib |
ENSG00000272824.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000272832.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tipifarnib |
ENSG00000272862.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Tipifarnib |
ENSG00000272864.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tipifarnib |
ENSG00000272871.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tipifarnib |
ENSG00000272871.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000272885.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000272892.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tipifarnib |
ENSG00000272914.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000272942.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tipifarnib |
ENSG00000272993.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Tipifarnib |
ENSG00000273001.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000273001.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tipifarnib |
ENSG00000273004.1 |
Predicted lncRNA |
Sarcoma |
|
| Tipifarnib |
ENSG00000273009.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tipifarnib |
ENSG00000273011.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tipifarnib |
ENSG00000273015.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000273027.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000273056.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tipifarnib |
ENSG00000273056.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tipifarnib |
ENSG00000273065.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000273077.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000273081.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tipifarnib |
ENSG00000273084.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tipifarnib |
ENSG00000273091.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tipifarnib |
ENSG00000273139.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Tipifarnib |
ENSG00000273160.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tipifarnib |
ENSG00000273174.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000273176.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000273179.1 |
Predicted lncRNA |
Sarcoma |
|
| Tipifarnib |
ENSG00000273203.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000273237.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Tipifarnib |
ENSG00000273293.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Tipifarnib |
ENSG00000273311.1 |
Predicted lncRNA |
Sarcoma |
|
| Tipifarnib |
ENSG00000273341.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tipifarnib |
ENSG00000273350.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Tipifarnib |
ENSG00000273356.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tipifarnib |
ENSG00000273372.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000273373.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000273384.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000273399.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000273402.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000273442.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Tipifarnib |
ENSG00000273449.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000273456.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Tipifarnib |
ENSG00000273472.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Tipifarnib |
ENSG00000273473.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Tipifarnib |
ENSG00000273474.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Tipifarnib |
ENSG00000273476.1 |
Predicted lncRNA |
Esophageal cancer |
|